Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures.
about
Neuro-modulating effects of honokiol: a reviewEffect of natural exogenous antioxidants on aging and on neurodegenerative diseasesElimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme CellsHonokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.Alleviation of kainic acid-induced brain barrier dysfunction by 4-o-methylhonokiol in in vitro and in vivo modelsMagnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in miceThe natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptorsEffects of mixed herbal extracts from parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix (KIOM-79) on cardiac ion channels and action potentials.Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory painScreening active anti-breast cancer compounds from Cortex Magnolia officinalis by 2D LC-MS.Honokiol, a neuroprotectant against mouse cerebral ischaemia, mediated by preserving Na+, K+-ATPase activity and mitochondrial functions.Neuroprotective effects of honokiol: from chemistry to medicine.Protective action of 9-hydroxypinoresinol against oxidative damage in brain of mice challenged with kainic acid.Inhibitory Effects of Honokiol on the Voltage-Gated Potassium Channels in Freshly Isolated Mouse Dorsal Root Ganglion Neurons.Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice.
P2860
Q21129428-0CBA9F37-402C-44CC-9574-0D25971D9437Q28289119-F2E2603A-096E-4C14-B8C6-BA58D98B55A3Q30048454-8B3E9B99-2529-4C03-9F83-1673787EEC6AQ33563809-551A4D85-1DE5-4E8E-BD7D-4E371F8BB2B3Q35061427-D3397ACD-D6C1-436B-A203-5D91B349E2D4Q35564297-38B944A0-5865-4418-9C52-734D1B4AF37DQ36837698-F01863DE-3DB2-49C2-95B4-2A1F6AAD3E3CQ37232020-50BCA57F-618F-461F-B7B2-A90A05151C4DQ37396659-73E270BA-2644-4AEA-B4D7-5A3786747DF6Q39196167-6919C9BF-8AEB-4354-B314-0BB33B566813Q48096880-3C0DB75E-6056-4BB0-96A8-8A61513ACB45Q48150702-B00EEDB3-8B24-4B70-92AB-6F8EACDC7521Q48205658-C800311D-ADCC-4D76-8A14-340F783292D8Q48234331-B6A64D18-B968-42EF-B914-B439280FB120Q48702102-AD62E81E-4D1F-470F-A9FA-67113A3DC76C
P2860
Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Differential inhibitory effect ...... als and NMDA-induced seizures.
@en
Differential inhibitory effect ...... als and NMDA-induced seizures.
@nl
type
label
Differential inhibitory effect ...... als and NMDA-induced seizures.
@en
Differential inhibitory effect ...... als and NMDA-induced seizures.
@nl
prefLabel
Differential inhibitory effect ...... als and NMDA-induced seizures.
@en
Differential inhibitory effect ...... als and NMDA-induced seizures.
@nl
P2093
P1433
P1476
Differential inhibitory effect ...... nals and NMDA-induced seizures
@en
P2093
Chien-Hsin Ko
Hwei-Hsien Chen
Yi-Ruu Lin
P304
P356
10.1016/J.NEUROPHARM.2005.04.009
P577
2005-09-01T00:00:00Z